Arrowhead Pharmaceuticals Inc Financial Flexibility Index
Arrowhead Pharmaceuticals Inc financial flexibility index. Arrowhead Pharmaceuticals Inc (ARWR) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of $27.98 Million (operating CF $20.49 Million minus capex $7.49 Million) represents 0% of total liabilities ($881.88 Million). Explore Arrowhead Pharmaceuticals Inc (ARWR) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Arrowhead Pharmaceuticals Inc (1997–2025)
Financial flexibility index of Arrowhead Pharmaceuticals Inc from 1997 to 2025. Historical Financial Flexibility Index trend for Arrowhead Pharmaceuticals Inc across 29 annual periods. Check Arrowhead Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Arrowhead Pharmaceuticals Inc Financial Flexibility Index by Year (1997–2025)
Arrowhead Pharmaceuticals Inc financial flexibility index by year from 1997 to 2025. Year-by-year free cash flow to debt coverage for Arrowhead Pharmaceuticals Inc. For the full cash flow conversion analysis, see Arrowhead Pharmaceuticals Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | $202.22 Million | $179.55 Million | $947.02 Million | ▲ +163.0% |
| 2024 | -0.34x | $-321.38 Million | $-462.85 Million | $948.74 Million | ▼ -809.3% |
| 2023 | 0.05x | $22.85 Million | $-153.89 Million | $478.39 Million | ▲ +115.7% |
| 2022 | -0.30x | $-83.35 Million | $-136.13 Million | $273.60 Million | ▼ -147.1% |
| 2021 | 0.65x | $194.79 Million | $171.22 Million | $301.33 Million | ▲ +147.0% |
| 2020 | -1.37x | $-83.44 Million | $-95.39 Million | $60.72 Million | ▼ -178.6% |
| 2019 | 1.75x | $185.04 Million | $173.03 Million | $105.81 Million | ▲ +162.5% |
| 2018 | -2.80x | $-45.80 Million | $-47.22 Million | $16.37 Million | ▼ -304.4% |
| 2017 | -0.69x | $-16.02 Million | $-23.94 Million | $23.16 Million | ▲ +62.1% |
| 2016 | -1.83x | $-60.57 Million | $-64.43 Million | $33.15 Million | ▲ +35.1% |
| 2015 | -2.81x | $-63.74 Million | $-65.71 Million | $22.65 Million | ▼ -40.6% |
| 2014 | -2.00x | $-33.70 Million | $-35.42 Million | $16.83 Million | ▼ -23.9% |
| 2013 | -1.62x | $-18.74 Million | $-19.03 Million | $11.59 Million | ▲ +16.1% |
| 2012 | -1.93x | $-14.86 Million | $-15.34 Million | $7.72 Million | ▼ -18.9% |
| 2011 | -1.62x | $-5.38 Million | $-5.39 Million | $3.32 Million | ▲ +10.0% |
| 2010 | -1.80x | $-7.69 Million | $-7.70 Million | $4.28 Million | ▲ +66.4% |
| 2009 | -5.36x | $-15.24 Million | $-15.28 Million | $2.84 Million | ▲ +1.4% |
| 2008 | -5.43x | $-26.90 Million | $-27.58 Million | $4.95 Million | ▲ +20.2% |
| 2007 | -6.80x | $-23.11 Million | $-23.87 Million | $3.40 Million | ▼ -43.4% |
| 2006 | -4.75x | $-13.86 Million | $-14.79 Million | $2.92 Million | ▲ +42.3% |
| 2005 | -8.23x | $-8.43 Million | $-9.10 Million | $1.02 Million | ▼ -244.2% |
| 2004 | -2.39x | $-1.65 Million | $-2.31 Million | $689.70K | ▼ -47.9% |
| 2003 | -1.62x | $-155.48K | $-157.60K | $96.18K | ▼ -2405.5% |
| 2002 | -0.06x | $-104.16K | $-105.83K | $1.61 Million | ▼ -6.5% |
| 2001 | -0.06x | $-81.81K | $-81.81K | $1.35 Million | ▲ +8.8% |
| 2000 | -0.07x | $-79.34K | $-80.09K | $1.19 Million | ▼ -103.4% |
| 1999 | -0.03x | $-35.22K | $-35.22K | $1.08 Million | ▼ -92.0% |
| 1998 | -0.02x | $-46.15K | $-46.15K | $2.71 Million | ▼ -1100.9% |
| 1997 | 0.00x | $4.56K | $4.56K | $2.68 Million | — |